Micro(nano)plastics in the Development of Myocardial Fibrosis: From Clinical Detection to Molecular Mechanism

Yilin Pan1, Linqi Liu2, Jiyuan Luo1

  • 1Department of Cardiac Surgery (Y.P., J. Luo, X.Z., L.Z., Z.P., G.S., K.H., X.Y.), Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Circulation Research
|April 27, 2026
PubMed
Abstract

Insights

Micro(nano)plastics (MNPs) accumulate in human heart tissue and correlate with fibrosis. Exposure to polystyrene exacerbates cardiac dysfunction and fibrosis in mice, suggesting MNPs contribute to heart disease.

Area of Science:

  • Environmental Science
  • Toxicology
  • Cardiology

Background:

  • Micro(nano)plastics (MNPs) are widespread environmental pollutants.
  • Their presence and impact on human cardiac tissue, specifically myocardial fibrosis, are not well understood.

Purpose of the Study:

  • To investigate the association between myocardial MNP burden and fibrosis severity in humans.
  • To evaluate the mechanistic role of MNPs in cardiac fibrosis using a mouse model.

Main Methods:

  • Human cardiac tissues (n=33) analyzed for MNP burden and fibrosis.
  • Mice exposed to polystyrene nanoplastics and isoprenaline; cardiac function and fibrosis assessed.
  • Multiomics (transcriptomics, metabolomics, 16S rRNA sequencing) used to identify MNP-related pathways.

Main Results:

  • MNPs detected in all human cardiac samples; higher MNP levels correlated with increased fibrosis.
  • Polystyrene and PVC enriched in fibrotic tissues.
  • Mouse studies showed polystyrene exacerbated cardiac dysfunction and fibrosis, activating inflammatory and profibrotic pathways.

Conclusions:

  • Myocardial MNP burden, especially nanoplastics, is linked to increased fibrosis in humans.
  • Experimental polystyrene exposure worsens stress-induced cardiac remodeling in mice.
  • Inflammatory, extracellular matrix, and metabolic pathways mediate MNP-associated cardiotoxicity.